RAFAEL HOLDINGS, INC. Income (Loss) Attributable to Parent, before Tax
RAFAEL HOLDINGS, INC. (RFL) reported Income (Loss) Attributable to Parent, before Tax of $6.10 million for the 3-month period ending 2024-01-31, per its 10-Q filed 2024-03-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossAttributableToParent · last filed 2024-03-14
- RAFAEL HOLDINGS, INC. income (loss) attributable to parent, before tax for the quarter ending 2024-01-31 was $6.10M.
- RAFAEL HOLDINGS, INC. income (loss) attributable to parent, before tax for the quarter ending 2023-10-31 was $3.50M, a 32.69% decline year-over-year.
- RAFAEL HOLDINGS, INC. income (loss) attributable to parent, before tax for the quarter ending 2023-04-30 was -$2.00K, a 100.04% decline year-over-year.
- RAFAEL HOLDINGS, INC. income (loss) attributable to parent, before tax for the quarter ending 2023-01-31 was -$3.20M, a 252.38% decline year-over-year.
| Period end | Income (Loss) Attributable to Parent, before Tax 3 month | Income (Loss) Attributable to Parent, before Tax 3 month as first filed | Income (Loss) Attributable to Parent, before Tax 6 month | Income (Loss) Attributable to Parent, before Tax 6 month as first filed | Income (Loss) Attributable to Parent, before Tax 9 month |
|---|---|---|---|---|---|
| 2024-01-31 | $6.10M 10-Q · filed 2024-03-14 | $2.60M 10-Q · filed 2024-03-14 | |||
| 2023-10-31 | $3.50M 10-Q · filed 2023-12-14 | ||||
| 2023-04-30 | -$2.00K 10-Q · filed 2023-06-13 | -$3.20M derived: sum of 2 quarters · filed 2024-03-14 | $6.00K 10-Q · filed 2023-06-13 | ||
| 2023-01-31 | -$3.20M 10-Q · filed 2024-03-14 | $4.00K 10-Q · filed 2023-03-14 | -$8.40M 10-Q · filed 2024-03-14 | $4.00K 10-Q · filed 2023-03-14 | |
| 2022-10-31 | $5.20M 10-Q · filed 2023-12-14 | $0.00 10-Q · filed 2022-12-13 | |||
| 2022-04-30 | $5.00M 10-Q · filed 2023-06-13 | $7.10M derived: sum of 2 quarters · filed 2023-06-13 | $135.30M 10-Q · filed 2023-06-13 | ||
| 2022-01-31 | $2.10M 10-Q · filed 2023-03-14 | $130.30M 10-Q · filed 2023-03-14 | |||
| 2021-10-31 | $128.80M 10-Q · filed 2022-12-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |